Sino Bio­phar­m's in­voX to re­struc­ture, like­ly cut­ting about 60 roles

On­col­o­gy and res­pi­ra­to­ry drug de­vel­op­er in­voX Phar­ma is fine-tun­ing its pipeline and ex­pects to cut about one-third of its em­ploy­ees, the com­pa­ny con­firmed to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER